Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29682390 | 0.97 | — | — | |
| SCHEMBL890738 | 0.97 | — | — | |
| SCHEMBL14951410 | 0.78 | ALDH1A1 (0.44) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL28029391 | 0.77 | HTR7 (0.35) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL812717 | 0.76 | ALDH1A1 (0.43) | LMNAALDH1A1KDM4ERAB9APOLB | |
| SCHEMBL2783311 | 0.75 | ALDH1A1 (0.39) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL31412108 | 0.75 | APOBEC3G (0.46) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL29543575 | 0.75 | LMNA (0.57) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL3282096 | 0.75 | LMNA (0.57) | HTR7MAOAMAOBLMNAALDH1A1 | |
| SCHEMBL224791 | 0.75 | APOBEC3G (0.46) | HTR7MAOAMAOBLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3653616-B1 | FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2021-10-27 | — | — | EP | disclosed |
| US-20200161557-A1 | FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-05-21 | — | — | US | disclosed |
| EP-3653616-A1 | FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2020-05-20 | — | — | EP | disclosed |
| EP-2583326-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| WO-2011158211-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | WO | disclosed |
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-4857549-A | Antitumor compounds | SMITHKLINE BECKMAN CORPORATION (US) | 1989-08-15 | — | — | US | disclosed |
| EP-0151046-B1 | ANTITUMOR PHARMACEUTICAL COMPOSITIONS AND COMPOUNDS FOR TREATING TUMORS EMPLOYING (ALPHA-OMEGA-BIS(DISUBSTITUTEDPHOSPHINO)-HYDROCARBON) DIGOLD(I), DIGOLD(III), DISILVER(I), AND DICOPPER(I) DERIVATIVES | SMITHKLINE BECKMAN CORPORATION (US) | 1989-06-14 | — | — | EP | disclosed |
| US-4766226-A | Antitumor pharmaceutical compositions and methods for treating tumors employing α,ω-bis(disubstitutedphosphino)hydrocarbon derivatives or [α, ω-bis(disubstitutedphosphino)hydrocarbon] di | SMITHKLINE BECKMAN CORPORATION (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0151046-A2 | Antitumor pharmaceutical compositions and compounds for treating tumors employing (alpha-omega-bis(disubstitutedphosphino)-hydrocarbon) digold(I), digold(III), disilver(I), and dicopper(I) derivatives | SMITHKLINE BECKMAN CORPORATION (US) | 1985-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | PPOX, JUP, CRY2 | HTR7 1340/4885MAOA 3243/4885MAOB 3503/4885 |
| US-20200161557-A1 | FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | NCS1, FOXK1, ESR1 | HTR7 4052/4885MAOA 2448/4885MAOB 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.